Sania Therapeutics
Sania Therapeutics is a startup headquartered in London, United Kingdom, founded in 2021. It has raised at least $5.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Sania Therapeutics has raised at least $5.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Sania Therapeutics sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in London
- Abtrace
- Adjsoft
- Aeon Energy
- Amphibio
- Anserine Labs
- APIContext
- Apoha
- AppyParking
- Archangel Lightworks
- Arda Biomaterials
- Bark
Related
- Innovation profile of London
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Sania Therapeutics do?
Sania Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Sania Therapeutics raised?
At least $5.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Sania Therapeutics based?
Sania Therapeutics is headquartered in London, United Kingdom.
When was Sania Therapeutics founded?
Sania Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.